NHS Framework Agreement, Branded Medicines for London and South of England

NHS EnglandcontractFind a TenderRef ocds-h6vhtk-02ac5732014L0024active
View buyer

Estimated value

goods

Awarded value

Suppliers

114

28 SME

Lots

6

114 awarded

Published

17 Sept 2021

Total lots

6

Awarded

6

0 pending

Estimated total

Awarded total

Lot 1cancelled

CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B.

Award value

Start

31 Aug 2021

End

31 Aug 2023

Estimated

CPV

33600000
Lot 4cancelled

CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B.

Award value

Start

31 Aug 2021

End

31 Aug 2022

Estimated

CPV

33600000
Lot 2cancelled

CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche.

Award value

Start

31 Aug 2021

End

31 Aug 2022

Estimated

CPV

33600000
Lot 3cancelled

CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A.

Award value

Start

31 Aug 2021

End

31 Aug 2023

Estimated

CPV

33600000
Lot 6cancelled

CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab

Award value

Start

31 Aug 2021

End

28 Feb 2022

Estimated

CPV

33600000
Lot 5cancelled

CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche.

Award value

Start

31 Aug 2021

End

31 Aug 2022

Estimated

CPV

33600000